Pharma & Biotech
ImmunoPrecise Antibodies is expanding its therapeutic offerings as a global full-service antibody provider
Medexus Pharmaceuticals is commercializing a pipeline of more than 20 different drugs
TIMIA Capital's revenue-based financing aims to lever up tech entrepreneurs
Only registered members can use this feature.
Copyright © Proactive Investors 2019.
All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC.